FDA Alert: Byetta (exenatide) - Renal Failure
Links shared publicly online about this topic.
- 1,631total visits
FDA Alert: Byetta (exenatide) - Renal Failure
View full resource at drugs.com
Tags: Diabetes Type 2 Medication, Diabetes Medication, Kidney Health, Urinary System, Kidney Disease, FDA, Byetta, Safety
Most Recently Shared on November 3, 2009 at 1:16 am By:
FDA Alert - Byetta Label Revised to Include Safety Information on Possible Kidney Problems - http://bit.ly/2KuyKU
FDA warns of renal failure with Byetta - MPR
empr.com — “The FDA has notified healthcare professionals that the Prescribing Information for Byetta (exenatide injection, from Amylin and Lilly) has been revised to include information on post-marketing reports of altered kidney function, including acute renal failure and insufficiency.” View full resource at empr.com
Most Recently Shared on November 3, 2009 at 3:21 pm By:
MPR News: FDA warns of renal failure with Byetta: The FDA has notified healthcare professionals that the Prescribing... http://bit.ly/2dvG8g
FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
fda.gov — “The U.S. Food and Drug Administration today acted on new safety information about possible kidney function problems, including kidney failure, in patients taking Byetta (exenatide), a drug used to treat Type 2 diabetes.” View full resource at fda.gov
Most Recently Shared on November 2, 2009 at 8:19 pm By:
FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems. Read the press release here: http://tinyurl.com/yfmgmf9
Advertisement
